How many years of comparable data are there for Early-demographic dividend and Iran?

10 years are reported by both, from 2015 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Early-demographic dividend vs Iran: Immunization, Hib3 (% of children ages 12-23 months)

Early-demographic dividend

86.1%

in 2024

Iran

98.0%

in 2024

Early-demographic dividend rank

17th

Iran rank

20th

Immunization, Hib3 (% of children ages 12-23 months) over time

Early-demographic dividend
Iran

How they compare

Iran currently reports 98.0% against 86.1% in Early-demographic dividend, a difference of 11.9%.

That makes Iran's figure about 1.1 times Early-demographic dividend's.

Across all 10 years both countries report, Iran has been ahead every year.

Early-demographic dividend ranks 17th and Iran ranks 20th of 43 groups.

Iran has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade	Early-demographic dividend	Iran	Difference	Ahead
2010s	82.3%	98.8%	16.5%	Iran
2020s	84.4%	98.6%	14.2%	Iran

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Early-demographic dividend or Iran?: Iran, at 98.0% against 86.1% in Early-demographic dividend as of 2024.
What is the difference in immunization, hib3 between Early-demographic dividend and Iran?: 11.9%, with Iran ahead.
How many years of comparable data are there for Early-demographic dividend and Iran?: 10 years are reported by both, from 2015 to 2024.
How do Early-demographic dividend and Iran rank globally for immunization, hib3?: Early-demographic dividend ranks 17th and Iran ranks 20th of 43 groups.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Early-demographic dividend vs Iran: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 12 November 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/early-demographic-dividend/iran-islamic-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/early-demographic-dividend/iran-islamic-rep/">Early-demographic dividend vs Iran: Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 29 October 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.